Is Abeona Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: ABEO) stock is to Buy ABEO stock.
Out of 2 analysts, 1 (50%) are recommending ABEO as a Strong Buy, 0 (0%) are recommending ABEO as a Buy, 1 (50%) are recommending ABEO as a Hold, 0 (0%) are recommending ABEO as a Sell, and 0 (0%) are recommending ABEO as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year ABEO price target, the average ABEO price target is $23.00, with the highest ABEO stock price forecast at $40.00 and the lowest ABEO stock price forecast at $6.00.
On average, Wall Street analysts predict that Abeona Therapeutics's share price could reach $23.00 by Nov 14, 2023. The average Abeona Therapeutics stock price prediction forecasts a potential upside of 718.51% from the current ABEO share price of $2.81.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.